PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.49%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.01%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.42%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
0.44%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
-4.70%
Negative net income growth while NXPI stands at 14.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.35%
Negative EPS growth while NXPI is at 15.38%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.35%
Negative diluted EPS growth while NXPI is at 16.22%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.46%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.54%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.15%
Dividend growth of 0.15% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-61.47%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-64.74%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
62.88%
10Y revenue/share CAGR 1.25-1.5x NXPI's 55.75%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
68.66%
5Y revenue/share CAGR 1.25-1.5x NXPI's 55.75%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-5.06%
Negative 3Y CAGR while NXPI stands at 17.55%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
88.46%
10Y OCF/share CAGR at 50-75% of NXPI's 165.10%. Martin Whitman might fear a structural deficiency in operational efficiency.
117.10%
5Y OCF/share CAGR at 50-75% of NXPI's 165.10%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-3.34%
Negative 3Y OCF/share CAGR while NXPI stands at 2043.68%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
112.73%
Similar net income/share CAGR to NXPI's 116.67%. Walter Schloss would see parallel tailwinds or expansions for both firms.
3278.82%
5Y net income/share CAGR above 1.5x NXPI's 116.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-21.06%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
40.88%
Equity/share CAGR of 40.88% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
36.00%
Equity/share CAGR of 36.00% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
8.43%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
1308.17%
Dividend/share CAGR of 1308.17% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
171.86%
Dividend/share CAGR of 171.86% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
129.32%
3Y dividend/share CAGR of 129.32% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.64%
AR growth well above NXPI's 8.86%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.98%
Inventory is declining while NXPI stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.02%
Negative asset growth while NXPI invests at 0.62%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.28%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
9.58%
Debt growth far above NXPI's 7.89%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
5.78%
R&D dropping or stable vs. NXPI's 12.50%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.90%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.